Evidence map›Paper›PMID 24082173›Full record

ArticleIndian journal of dermatology2013

The rate and pattern of bcl-2 and cytokeratin 15 expression in trichoepithelioma and nodular Basal cell carcinoma: a comparative study.

Shahram Sabeti, Farhad Malekzad, Mehrdad Ashayer, Rohollah F Fouladi, Kambiz K Hesari, Mihan P Toutkaboni, Shima Younespour

Abstract read
In one paragraph

Article in Indian journal of dermatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shahram SabetiLoghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Farhad Malekzad
Mehrdad Ashayer
Rohollah F Fouladi
Kambiz K Hesari
Mihan P Toutkaboni
Shima Younespour

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextHistopathological evaluations can differentiate between clinically resembling trichoepithelioma (TE) and basal cell carcinoma (BCC) unless the biopsy specimens are small or superficial. Previous studies used immunohistochemical evaluation for Bcl-2 and cytokeratin 15 (CK15), in attempts to differentiate between these two entities, with heterogeneous findings.

aimsThis study intended to compare the rate and patterns of Bcl-2 and CK15 expressions between specimens of TE and nodular BCC. SETTINGS AND

designCase-series including formalin-fixed, paraffin-embedded cutaneous biopsies. SUBJECTS AND

methodsTwenty-two BCC and 12 TE specimens were stained for Bcl-2 and CK15 and examined microscopically. The rate and patterns of expressions were compared between the two groups. STATISTICAL ANALYSIS USED: Statistical analysis was performed using the statistical software (SPSS version 16.0; SPSS Inc., Chicago, IL, USA), Pearson Chi-square, or Fisher's exact tests, wherever appropriate.

resultsThe two groups were comparable for the expression rate and patterns of Bcl-2 (86.4%: 5 central, 14 diffuse in BCC vs. 83.3%: 2 central, 8 diffuse in TE; P = 0.59 and 0.54 for rate and pattern, respectively). The rate of CK15 expression was significantly higher in TE specimens (66.7%: 4 central, 3 diffuse, 1 peripheral vs. 4.5%: 1 central; P < 0.001). The positive likelihood ratio in distinguishing the two neoplasms was 14.7 (95% confidence interval: 2.1-103.7).

conclusionsCK15 but not Bcl-2 staining may help in differentiating between BCC and TE even in BCCs with follicular differentiation.

Indexed as

Bcl-2cytokeratin 15nodular basal cell carcinomatrichoepithelioma

Identifiers

PMID24082173
PMCPMC3778768

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.